Hybridization News and Research

RSS

Gut microbiome is a reality in fetal life also

A study published in the Journal of Clinical Investigation shows that in both mice and humans, the fetal gut has its own microbiome, which is probably derived straight from the maternal organism.

24 Oct 2019

Spatial Gene Expression Profiling of Neurological Disorders

In this interview, Cedric Uytingco discusses the key benefits of being able to visualize gene expression patterns in neurological samples.

From 10x Genomics, Inc. 7 Oct 2019

Study may help scientists to learn more about the causes of chronic pain

Researchers from North Carolina State University have found that inflammation increases neuronal activity, gene expression and sensory nerve (neurite) outgrowth in neurons involved in thermal - but not physical- sensations in mice.

27 Sep 2019

Maternal behavior in mice linked to oxytocin-sensitive cells in the female brain

A startling new study shows that cells that are exquisitely sensitive to oxytocin are found in a tiny region in the brains of female but not male mice. This could be of great importance in explaining maternal behavior in females and eventually in treating social disorders like postpartum depression and autism spectrum disorder.

25 Jul 2019

Researchers discover 'mystical' psychedelic compound in normal brains

In the past few years, thrill-seekers from Hollywood, Silicon Valley and beyond have been travelling to South America to take part in so-called Ayahuasca retreats.

27 Jun 2019

OGT expands SureSeq NGS portfolio with a complete library preparation solution

Oxford Gene Technology (OGT), The Molecular Genetics Company, has expanded its SureSeq portfolio with a complete library preparation solution for hybridization-based target capture in NGS, making its market-leading coverage uniformity and expertise even more accessible.

From Oxford Gene Technology 13 Jun 2019

Roche Diagnostics launches first in vitro diagnostic ROS1 immunohistochemistry assay

Roche Diagnostics today announced the launch of the VENTANA ROS1 Antibody, the first and only in vitro diagnostic ROS1 immunohistochemistry assay. The test detects the presence of ROS1 protein in tissue, and may be useful in identifying ROS1-positive lung cancer cases.

From Roche Sequencing and Life Science 10 Jun 2019

IDT announces significant NGS portfolio expansion

Demonstrating its advocacy for genomics research, Integrated DNA Technologies announces a significant expansion to its NGS portfolio.

From Integrated DNA Technologies 10 May 2019

Study describes unusual occurrence of novel schistosome hybrids infecting Malawi children

LSTM's Professor Russell Stothard is senior author on a new paper in which researchers from the UK and Malawi have described the unusual occurrence of novel schistosome hybrids infecting children along the Shire River Valley.

9 May 2019

New resource accelerates use of FISH techniques to study spatial organization of DNA in cells

Researchers at Karolinska Institutet present a publicly available resource that can accelerate the use of so-called FISH techniques for studying how the genome is spatially organised in the cell nucleus.

9 Apr 2019

Garvan researchers develop more accurate method to diagnose cancer subtypes

Developed by researchers at the Garvan Institute of Medical Research, this potential diagnostic method screens a cancer sample for 'fusion genes', estimated to be linked to one in five cancers, and may provide a more accurate snapshot of rearranged DNA found in cancer.

28 Mar 2019

Wyss Technology licensed by Sherlock Biosciences to create affordable molecular diagnostics

Harvard University has granted a worldwide exclusive license to Sherlock Biosciences, Inc. to develop and commercialize technology from the Wyss Institute for Biologically Inspired Engineering to create a highly sensitive, nucleic acid-based diagnostic platform that can rapidly deliver accurate and inexpensive results for a vast range of needs in virtually any setting.

22 Mar 2019

OGT announces expansion of Cytocell operations in the UK

Oxford Gene Technology, The Molecular Genetics Company, has announced that it is expanding its Cytocell operations with a move to a new facility in Cambridge, UK.

From Oxford Gene Technology 27 Feb 2019

Biologist uses new grant to find ways to eliminate schistosomiasis

A biologist at The University of Texas at Arlington is using a new grant to look for ways to finish off a disease that has stubbornly resisted all attempts to eradicate it.

22 Feb 2019

New technology can detect any virus that poses a threat to humans

Researchers have developed a computational method that designs molecular “baits” for any strains of virus known to infect humans, including Zika virus.

5 Feb 2019

New disease surveillance tool enables early detection of viral outbreaks

During the Zika virus outbreak of 2015-16, public health officials scrambled to contain the epidemic and curb the pathogen's devastating effects on pregnant women. At the same time, scientists around the globe tried to understand the genetics of this mysterious virus.

5 Feb 2019